IGC 8-K 2026-07-13

IGC Pharma, Inc. (IGC) 8-K dated 2026-07-13 — accession 0001185185-26-002922. This URL is the filing, not the IGC hub.

IGC Pharma, Inc. (IGC) is a biotechnology company listed on US.

IGC Pharma, Inc. filed a 8-K on 2026-07-13. Accession 0001185185-26-002922.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IGC revenue for 2025-12-31 was $869.0K. Net income was -$4.1M. Revenue was down 31.6% from 2025-03-31 to 2025-12-31. IGC currently screens at market cap $24.1M.

Not investment advice. The IGC SEC hub lists recent forms. The stock page is the research view.